What Vibcare Pharma does

Vibcare Pharma Pvt. Ltd., founded in 2014 and headquartered in Panchkula, Haryana, is an Indian private pharmaceutical manufacturer that operates primarily through a Propaganda Cum Distribution (PCD) franchise model. The company runs a WHO-GMP, EU PICS, and UK MHRA GMP certified in-house manufacturing facility producing a portfolio of more than 1,500 formulations across 11 branded therapeutic divisions (AUSPIN, CURE, GRACE, MIND, PRIMA, OPTHO, NURALZ, EVERMED, GENVIMAX, MEDANOR, and VENTILA) spanning allopathic and Ayurvedic products in dosage forms including tablets, capsules, syrups, injections, creams, eye drops, and respules. The certified plant supports both proprietary PCD franchise distribution and third-party contract manufacturing for other pharmaceutical brands.

The company's primary go-to-market is a B2B franchise and distribution network of 5,000+ partners across 27 Indian states, with each franchisee granted territorial exclusivity. Revenue is generated on a transaction-fee basis: franchise partners and stockists purchase at wholesale PTR (Price to Retailer) and PTS (Price to Stockist) rates on an advance "To Pay" basis, then resell to retailers and end consumers at MRP (Maximum Retail Price). Operational support includes same-day order processing, 72-hour dispatch, real-time tracking via SMS/email/WhatsApp, a partner mobile application for ordering and payments, online pricing calculators, and medico-marketing materials (visual aids, MR bags, doctor gifts) for field promotion. Co-founders Siddharth Singhal (Managing Director) and Sudhanshu Singhal (Director) lead the company, which employs 51–100 staff and has no disclosed external institutional investors.

Name

Vibcare Pharma

Legal name

Vibcare Pharma Pvt. Ltd.

Website

https://vibcare.co.in

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Vibcare Pharma is a WHO-GMP, EU PICS, and UK MHRA GMP certified Indian pharmaceutical manufacturer that distributes 1,500+ formulations through a 5,000-partner PCD franchise network across 27 states.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Pharmaceutical manufacturing
• PCD pharma franchise
• Generic medicines
• Contract manufacturing
• Ayurvedic formulations

Headquarters

HQ city

Haryana

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. PCD Pharma Franchise: Vibcare Pharma generates revenue through its PCD (Propaganda Cum Distribution) franchise model where franchise partners purchase pharmaceutical products at wholesale rates (PTR/PTS pricing) and sell to retailers and end consumers. Partners operate within allotted territories and pay in advance (To Pay basis) before invoice generation.
2. Third-Party Contract Manufacturing: The company offers fully integrated third-party contract manufacturing and development solutions, manufacturing products for other pharmaceutical brands under WHO-GMP protocols.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Vibcare Pharma manufactures and distributes a portfolio of 1,500+ WHO-GMP compliant pharmaceutical formulations across 11 therapeutic divisions through a PCD (Propaganda Cum Distribution) franchise model serving 5,000+ distribution partners across 27 Indian states. The company also provides third-party contract manufacturing services under WHO-GMP, EU PICS, and UK MHRA GMP certified protocols. Products span allopathic, Ayurvedic, and herbal formulations in dosage forms including tablets, capsules, syrups, injections, creams, eye drops, and nasal sprays.

Product overview

Vibcare Pharma is a WHO-GMP certified pharmaceutical company established in 2014, operating as a PCD (Propaganda Cum Distribution) pharma franchise and third-party manufacturing partner. The company offers a portfolio of over 1,500 WHO-GMP compliant formulations across 11 therapeutic divisions: AUSPIN, CURE, GRACE, MIND, PRIMA, OPTHO, NURALZ, EVERMED, GENVIMAX, MEDANOR, and VENTILA. The product portfolio spans multiple dosage forms including tablets, capsules, syrups, injections, creams, drops, dry syrups, respules, nasal sprays, and Ayurvedic herbal preparations. Core product highlights include antidiabetic medications (VIGLIM series, EZMIVIB), antimalarial injections (VIBONATE 120, FERLIB FCM 500), anti-infectives (CLINIVIB 600, ODOXICEF), topical preparations (PILOVIB, BETMOVIB PLUS), Ayurvedic supplements (ASHWAGANDHA, SAFED MUSLI, NURASTON), and respiratory products under the VENTILA division. The company operates an in-house manufacturing facility compliant with EU PICS and UK MHRA GMP standards, enabling competitive pricing through vertical integration. Business support tools include PTR/PTS calculators, profit margin calculators, and a mobile application for ordering and ledger management.

Differentiator

Problem solved

Functional benefit

Brands

• AUSPIN: Therapeutic division brand for pharmaceutical products
• CURE
• GRACE
• MIND
• PRIMA
• OPTHO
• NURALZ
• EVERMED
• GENVIMAX
• MEDANOR
• VENTILA

Products and services

• PCD Pharma Franchise Program A PCD (Propaganda Cum Distribution) pharma franchise program granting entrepreneur partners exclusive territorial rights to sell Vibcare's 1,500+ WHO-GMP-compliant pharmaceutical products. Partners receive marketing support, visual aids, promotional materials, dedicated account management, a partner mobile application for ordering, payments, and ledger access, same-day order dispatch, and real-time tracking via email, SMS, and WhatsApp. Targeted at entrepreneurs, stockists, and medical retailers across India.
• Third-Party Contract Manufacturing Fully integrated third-party contract manufacturing and development solutions producing pharmaceutical formulations for other brands under WHO-GMP, EU PICS, and UK MHRA GMP certified protocols. Targeted at pharmaceutical companies requiring cost-effective, high-quality production with international regulatory compliance.
• AUSPIN Division Products Therapeutic division offering various pharmaceutical formulations across multiple dosage forms.
• CURE Division Products Therapeutic division focused on various treatment categories including antidiabetic medications like EZMIVIB and VIGLIM series.
• GRACE Division Products Dermatological and topical formulations division including creams and anti-infective products.
• MIND Division Products Neuropsychiatric and CNS-focused therapeutic division.
• PRIMA Division Products Pediatric and anti-allergic formulations including drops and syrups like VIBAPTI and VIBMINIC.
• OPTHO Division Products Ophthalmic product division including eye drops like VIBROLEN EYE DROP.
• NURALZ Division Products Neurological and herbal Ayurvedic formulations including cardiac and kidney health products like LIPINURA and NURASTON.
• EVERMED Division Products Anti-infective and broad-spectrum antibiotic formulations including LAMONIC syrup.
• GENVIMAX Division Products General and multi-category formulations including ENERGYVIB nutritional supplements and pain management products.
• MEDANOR Division Products Various therapeutic formulations across multiple categories.
• VENTILA Division Products Respiratory and ear/nose/throat product line including nasal sprays (AZESTAVIB F, MOTOVIB, METZOVIB), respules (BUDOVIB), VIBCAPS inhalers (FORMOVIB, SERAVIB), and ear drops (OTOVIB) for respiratory and ENT conditions.

Quantifiable outcome

• Same-day order dispatch with real-time billing, dispatch, and tracking updates via email, SMS, and WhatsApp
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Mankind Pharma: One of India's largest domestic-focused pharma companies with a wide PCD and franchise distribution network and a generic + OTC portfolio. Comparable to Vibcare in product breadth and channel model, but at vastly greater scale and capitalisation.
• Torrent Pharmaceuticals: Established Indian pharma company with branded generics, chronic-care focus and pan-India distribution. Comparable therapeutic mix and regulatory footprint, but at substantially larger scale.
• Cipla: One of India's largest pharma companies with global generics, APIs and domestic branded generics across multiple therapeutic areas. Overlaps Vibcare on chronic-disease generics, Indian channel distribution, and regulatory depth.
• Alembic Pharmaceuticals: Vertically integrated Indian pharma with API + finished dosage manufacturing, USFDA/UK MHRA plants and broad domestic generics franchise. Comparable manufacturing footprint and generic + specialty therapeutic mix to Vibcare, at materially greater scale.
• Intas Pharmaceuticals: Indian multinational pharma with strong generics, biosimilars and contract manufacturing businesses. Comparable in third-party manufacturing and chronic / acute therapeutic categories; far larger and globally diversified.
• Alkem Laboratories: Major Indian generic and branded pharma manufacturer with extensive domestic distribution and international regulatory certifications. Overlaps Vibcare in generic formulations, Indian channel coverage, and multi-therapeutic portfolio.
• Lupin: Global Indian pharma major with WHO-GMP / USFDA / UK MHRA compliant plants and a broad generic portfolio. Directly comparable on regulatory standards and product breadth; differs sharply on global market reach and scale.

Direct peers

• Medipol Pharmaceuticals India: Indian PCD pharma franchise company offering a broad generic and Ayurvedic product portfolio through distributor partners. Closely matches Vibcare's PCD franchise model, target customer (stockists / entrepreneurs), and breadth of formulations.
• Akums Drugs & Pharmaceuticals: India's largest contract pharma manufacturer offering third-party / loan-licence manufacturing across therapeutic categories. Most directly comparable to Vibcare's contract manufacturing + branded distribution model.
• Zenacts Pharma: Indian PCD pharma franchise and third-party manufacturer marketing WHO-GMP products to franchise partners. Directly comparable go-to-market model, customer base and product breadth to Vibcare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/vibcarepharma
• YouTubeyoutube.com/VibcarePharma
• Facebookfacebook.com/vibcarepharma
• Instagraminstagram.com/vibcare_pharma
• LinkedInlinkedin.com/company/vibcare-pharma-pvt-ltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vibcare Pharma